Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for prevention of delirium in ICU patients
IRCT20240908062983N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thiamine in delirium (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Prevention of delirium in ICU patients. Started Mar 2025; status: completed.
02
Drugs
thiamine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20240908062983N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240908062983N1.